In Montenegro, there is no reason to panic because of shortages of pentavalent and hexavalent vaccines, because children will be vaccinated with those that exist, said the director of Montefarm, Budimir Stanišić.
Not a single bidder responded to the tender for the procurement of the pentavalent vaccine, which protects children from five diseases, and supplies for revaccination are available until March.
Stanišić told the MINA agency that there is no reason to panic and that the children will be properly vaccinated.
"The revaccination will be with individual vaccines according to the procedure that the Institute for Public Health will determine with the health centers," said Stanišić.
As he said, pentavalent and hexavalent vaccines are not available in the entire region.
"There are none in Serbia, Macedonia, Bosnia and Herzegovina and Montenegro. Procurement is very problematic. Vaccination will not be problematic in the next few months and children will be properly vaccinated," said Stanišić.
He explained that at the meeting in the Health Insurance Fund, it was agreed that the Director of the Fund, Kenan Hrapović, and the Minister of Health, Miodrag Radunović, should talk as soon as possible with the representatives of the producers of problematic vaccines about whether there will be any for the Southeast European market.
"After that discussion, we will have a clearer situation regarding further procurement. If there are those vaccines, we will procure them in a shortened procedure, and if not, then we will have to procure vaccines in a shorter period in order to continue vaccination with other vaccines," explained Stanišić.
He explained that representatives of Montefarm and the director of the Institute for Public Health, Boban Mugoša, were also present at that meeting and that the situation on the vaccine market was analyzed.
Stanišić said that there is no official information about the cause of the shortage in Montenegro and the region.
"Unofficially, we have information that one of the components that make up pentavalent and hexavalent is not available at the manufacturer, and then the complete vaccine stops being produced," said Stanišić.
Another piece of information, he said, is that a larger quantity of those vaccines is directed towards another market, namely America.
Bonus video:
